In autoimmune diseases, the effects of IL-10 are only inhibitory; although, TGF-β can act synergistically with proinflammatory cytokines and even causes fibrotic lesions and promotes autoimmune pathologies [27]. Here, TGFB1 is linked to autoimmune disease.